Wednesday Aug 13
Lipocine: An Undervalued Biotech With An Approaching Catalyst
Lipocine's Phase III results for its lead compound LPCN-1021 are expected to be announced in the third quarter of 2014.
Tue Aug 12, 2014
Applied Clinical Trials
BioDelivery Sciences Announces BEMA Buprenorphine NDA Submission on...
The meeting was held on The positive outcome of the pre-NDA meeting allows BDSI and Endo to maintain expectations of an NDA filing with FDA for BEMA Buprenorphine in late 2014 or early 2015 as planned.
Mon Aug 11, 2014
Auxilium hires former Endo executive as new CFO
The Chesterbook, Pa. specialty biopharmaceutical company said Monday it has hired Andrew Saik at its CFO effective Aug. 18, 2014.
Fri Aug 08, 2014
Pain drug developer reels in $5M
Scilex Pharmaceuticals, a specialty pharmaceutical company working on new pain medications, raised $5 million in a private stock sale, according to documents filed with the Securities & Exchange Commission .
BioDelivery Sciences reports narrower loss in Q2
BioDelivery Sciences International reported a narrower loss in the second quarter as the Raleigh company's revenue surged 400 percent.
Wed Aug 06, 2014
Endo completes acquisition of DAVA Pharmaceuticals
Endo International plc today announced that it has completed the acquisition of DAVA Pharmaceuticals, Inc., a privately-held company specializing in generic pharmaceuticals, with a portfolio of marketed, pre-launch and pipeline products, for contingent on the achievement of certain sales milestones.
Mon Aug 04, 2014
Endo International PLC - 10-Q - Management's Discussion and Analysis...
The following Management's Discussion and Analysis of Financial Condition and Results of Operations describes the principal factors affecting the results of operations, liquidity and capital resources and critical accounting estimates at .
Sun Aug 03, 2014
Customer Interaction Solutions
Endo Names Cooke to Board of Directors [Health & Beauty Close - Up]
Endo International reported the appointment of Shane M. Cooke to the company's board of directors.
Sat Aug 02, 2014
Sterne Agee Increases Endo International PLC Price Target to $75.00
Sterne Agee's target price indicates a potential upside of 10.91% from the stock's previous close.
Thu Jul 31, 2014
Endo International's (ENDP) CEO Rajiv Kanishka Liyanaarchchie De...
Good day, ladies and gentlemen, and welcome to the Q2 2014 Endo International plc Earnings Conference Call.
Endo International revenues increase $719M to 1% in Q2 2014
Endo International plc today reported second quarter 2014 revenues of $719 million, an increase of 1 percent compared to second quarter 2013 revenues of $712 million.
Wed Jul 30, 2014
Tue Jul 29, 2014
Aurinia Adds Financial Expertise To Its Board Of Directors
Aurinia Pharmaceuticals Inc. today announced that Mr. Charles Rowland Jr. has joined its Board of Directors and will assume the role of Audit Committee Chair.
Tue Jul 22, 2014
Kimmel Center Elects New Chairman of Board of Directors
The Kimmel Center is proud to announce that the Board of Directors of Kimmel Center, Inc. elected David P. Holveck as its Chairman, effective July 1, 2014.